1 Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94. doi:https://doi.org/10.1016/S0140-6736(09)60692-9.
2 Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11. doi:https://doi.org/10.1016/S0140-6736(06)69208-8.
3 Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103(13):1759–64. doi:https://doi.org/10.1161/01.CIR.103.13.1759.
4 Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111(3):295–301. doi:https://doi.org/10.1161/01.CIR.0000151097.30779.04.
5 Lamas GA, Mitchell GF, Flaker GC, Smith SC, Jr, Gersh BJ, Basta L, et al.; Survival and Ventricular Enlargement Investigators. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation. 1997;96(3):827–33. doi:https://doi.org/10.1161/01.CIR.96.3.827.
6 Trichon BH, Felker GM, Shaw LK, Cabell CH, O’Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91(5):538–43. doi:https://doi.org/10.1016/S0002-9149(02)03301-5.
7 Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335(19):1417–23. doi:https://doi.org/10.1056/NEJM199611073351902.
8 Avierinos J-FF, Gersh BJ, Melton LJ, 3rd, Bailey KR, Shub C, Nishimura RA, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106(11):1355–61. doi:https://doi.org/10.1161/01.CIR.0000028933.34260.09.
9 Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al.; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). [Guidelines on the management of valvular heart disease (version 2012)]. G Ital Cardiol (Rome). 2013;14(3):167–214. Article in Italian.
10 Taramasso M, Buzzatti N, La Canna G, Colombo A, Alfieri O, Maisano F. Interventional vs. surgical mitral valve therapy. Which technique for which patient? Herz. 2013;38(5):460–6. doi:https://doi.org/10.1007/s00059-013-3859-2.
11 Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde J-LL, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–65. doi:https://doi.org/10.1093/eurheartj/ehm001.
12 Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122(4):674–81. doi:https://doi.org/10.1067/mtc.2001.117277.
13 Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, et al.; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54(8):686–94. doi:https://doi.org/10.1016/j.jacc.2009.03.077.
14 Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et al.; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395–406. doi:https://doi.org/10.1056/NEJMoa1009355.
15 Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J. 2010;31(11):1373–81. doi:https://doi.org/10.1093/eurheartj/ehq050.
16 Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S, et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J. 2010;31(11):1382–9. doi:https://doi.org/10.1093/eurheartj/ehq051.
17 Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C, et al. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13(5):569–76. doi:https://doi.org/10.1093/eurjhf/hfr029.
18 Reichenspurner H, Schillinger W, Baldus S, Hausleiter J, Butter C, Schäefer U, et al.; ACCESS-EU Phase I Investigators. Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial. Eur J Cardiothorac Surg. 2013;44(4):e280–8. doi:https://doi.org/10.1093/ejcts/ezt321.
19 Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052–61. doi:https://doi.org/10.1016/j.jacc.2013.02.094.
20 Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Lüscher TF, et al.; Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J Am Coll Cardiol. 2014;64(9):875–84. doi:https://doi.org/10.1016/j.jacc.2014.06.1166.
21 Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37(8):703–12.
22 Auricchio A, Schillinger W, Meyer S, Maisano F, Hoffmann R, Ussia GP, et al.; PERMIT-CARE Investigators. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol. 2011;58(21):2183–9. doi:https://doi.org/10.1016/j.jacc.2011.06.061.
23 Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, et al.; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol. 2012;59(2):130–9. doi:https://doi.org/10.1016/j.jacc.2011.08.067.
24 Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, et al.; EVEREST II Investigators. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62(4):317–28. doi:https://doi.org/10.1016/j.jacc.2013.04.030.
25 Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al.; American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777–802. doi:https://doi.org/10.1016/S0894-7317(03)00335-3.
26 Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2(5):358–67. doi:https://doi.org/10.1016/S0894-7317(89)80014-8.
27 Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014;64(2):172–81. doi:https://doi.org/10.1016/j.jacc.2013.12.062.
28 Sürder D, Pedrazzini G, Gaemperli O, Biaggi P, Felix C, Rufibach K, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart. 2013;99(14):1034–40. doi:https://doi.org/10.1136/heartjnl-2012-303105.